Tenax Therapeutics (TENX) Operating Income (2016)
Historic Operating Income for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$42.2 million.
- Tenax Therapeutics' Operating Income fell 24887.04% to -$42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$63.5 million, marking a year-over-year increase of 2819.9%. This contributed to the annual value of -$19.5 million for FY2024, which is 13675.01% down from last year.
- Per Tenax Therapeutics' latest filing, its Operating Income stood at -$42.2 million for Q4 2016, which was down 24887.04% from -$4.5 million recorded in Q3 2016.
- Over the past 5 years, Tenax Therapeutics' Operating Income peaked at $68.9 million during Q2 2012, and registered a low of -$74.1 million during Q2 2013.
- Its 4-year average for Operating Income is -$7.5 million, with a median of -$3.2 million in 2012.
- Per our database at Business Quant, Tenax Therapeutics' Operating Income surged by 242467.64% in 2012 and then plummeted by 24887.04% in 2016.
- Quarter analysis of 4 years shows Tenax Therapeutics' Operating Income stood at -$682843.0 in 2012, then tumbled by 10746.09% to -$74.1 million in 2013, then skyrocketed by 83.66% to -$12.1 million in 2015, then plummeted by 248.87% to -$42.2 million in 2016.
- Its Operating Income stands at -$42.2 million for Q4 2016, versus -$4.5 million for Q3 2016 and -$4.7 million for Q2 2016.